US › Healthcare

Codexis Inc (CDXS)

US · Healthcare · Biotechnology

$1.43-1.38%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$15.2M
Revenue YoY
+102.1%
Net profit
$-8.7M
Profit YoY
+57.9%
EPS
$-0.10
EPS estimate
$-0.10
Net margin
-57.1%

EPS came in at -0.10 against a street estimate of -0.10 — a beat of 0.0%.

Key statistics

Market cap
$150.6M
Forward P/E
149.3
P/B
3.48
Book value
$0.48
EPS (TTM)
$-0.35
52-week high
$3.87
52-week low
$0.96
50-day MA
$2.33
200-day MA
$1.97
Beta
2.50

Analyst view

Analysts rate Codexis Inc a buy (5 buy, 2 hold, 0 sell out of 7) with an average price target of $6.58.

Shareholding

Insiders
6.26%
Institutions
70.82%

Largest institutional holders

FundStake
Aberdeen Group PLC8.07%
BlackRock Inc6.53%
Opaleye Management Inc6.31%
Nantahala Capital Management, LLC3.83%
Millennium Management LLC3.72%
Telemark Asset Management, LLC3.58%
Vanguard Capital Management, LLC3.41%
Ameriprise Financial Inc3.16%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Codexis Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.